Cimetidine in colorectal cancer--are the effects immunological or adhesion-mediated?
CitationCimetidine in colorectal cancer--are the effects immunological or adhesion-mediated? 2002, 86 (2):159-60 Br. J. Cancer
JournalBritish Journal of Cancer
- Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells.
- Authors: Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Suzuki H, Okamoto T
- Issue date: 2002 Jan 21
- Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression.
- Authors: Kobayashi K, Matsumoto S, Morishima T, Kawabe T, Okamoto T
- Issue date: 2000 Jul 15
- Cimetidine and colorectal cancer--old drug, new use?
- Authors: Morris DL, Adams WJ
- Issue date: 1995 Dec
- [Gastric acid secretion and histamine H2 receptor antagonists].
- Authors: Gespach C, Emami S, Di Gioia Y, Chastre E
- Issue date: 1990
- Cooperative inhibitory effects of antisense oligonucleotide of cell adhesion molecules and cimetidine on cancer cell adhesion.
- Authors: Tang NH, Chen YL, Wang XQ, Li XJ, Yin FZ, Wang XZ
- Issue date: 2004 Jan